Loading
Get Aetna Gr-69265 2021-2025
How it works
-
Open form follow the instructions
-
Easily sign the form with your finger
-
Send filled & signed form or save
How to fill out the Aetna GR-69265 online
Filling out the Aetna GR-69265 form for ® (aflibercept) precertification is an important process for ensuring proper treatment coverage. This guide provides a clear, step-by-step approach to completing the form accurately and efficiently online.
Follow the steps to complete the Aetna GR-69265 form online.
- Click the 'Get Form' button to obtain the Aetna GR-69265 form and open it for editing.
- Indicate the start of treatment by entering the start date in the designated fields.
- Provide the continuation of therapy date if applicable, filling in the date of the last treatment.
- Complete the precertification requested by section with your name and contact information.
- Fill out the patient information section, ensuring all fields are complete and legible. This includes the patient's first name, last name, address, contact numbers, and date of birth.
- Move on to the insurance information section. If the patient has other coverage, be sure to provide the relevant IDs and check the appropriate boxes.
- Fill in the prescriber information, including the prescriber's name, address, contact details, and specialty.
- In the dispensing provider or administration information section, provide details of the selected dispensing provider or pharmacy.
- For product information, indicate that the request is for (aflibercept), and specify the dose and directions for use.
- Complete the diagnosis information by providing the primary ICD code and any applicable secondary ICD code.
- In the clinical information section, select the appropriate diagnosis and answer questions regarding prior treatments and the patient's clinical response.
- In the acknowledgment section, ensure the request is signed and dated appropriately.
- Finally, review all entries for accuracy and completeness. You can then save changes, download, print, or share the completed form as needed.
Complete your Aetna GR-69265 form online today to ensure timely precertification for treatment.
The recommended dose for is 2 mg (0.05 mL of 40 mg/mL solution) administered by intravitreal injection every 4 weeks (approximately every 28 days, monthly) for the first 5 injections, followed by 2 mg (0.05 mL of 40 mg/mL solution) via intravitreal injection once every 8 weeks (2 months).
Industry-leading security and compliance
US Legal Forms protects your data by complying with industry-specific security standards.
-
In businnes since 199725+ years providing professional legal documents.
-
Accredited businessGuarantees that a business meets BBB accreditation standards in the US and Canada.
-
Secured by BraintreeValidated Level 1 PCI DSS compliant payment gateway that accepts most major credit and debit card brands from across the globe.